Robot-assisted surgery for intraventricular hemorrhage
Part of Brain & nervous system clinical trials.
This trial tests a robot-assisted, minimally invasive surgery to remove blood clots from the brain's fluid-filled spaces (ventricles) after a hemorrhage. The goal is to see if this approach improves recovery for patients with moderate to severe bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- You had a CT scan within 24 hours of your symptoms starting that showed a significant amount of bleeding in the brain's fluid-filled spaces (ventricles).
- If you have a separate area of bleeding in the brain, it must be smaller than 30 ml (about the size of a golf ball).
- Your surgery must happen within 72 hours of the first CT scan.
- Your level of consciousness (GCS score) is 14 or lower, meaning you are not fully alert.
- You do not have an untreated brain aneurysm, Moyamoya disease, or a bleeding tumor, and you are not on certain blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, less invasive surgery using a robot to help guide the doctor to drain blood from a brainstem bleed. It may be an option for people who can have surgery soon after the bleed and who have a certain level of consciousness.
This trial tests if a minimally invasive surgery guided by a robotic AI system can help people with moderate bleeding deep inside the brain (basal ganglia). If you qualify, the surgery would happen within 72 hours of your stroke.
This trial tests a new, less invasive brain surgery using a robotic arm guided by artificial intelligence (AI) to remove a large blood clot caused by a hemorrhagic stroke in the basal ganglia. It may be an option for people who can have surgery soon after the stroke and were previously independent.
This trial tests a minimally invasive robot-guided procedure to remove blood clots that develop after stroke treatment. The goal is to reduce brain damage and improve recovery in patients whose condition got worse after initial stroke therapy.
This trial tests a minimally invasive surgery guided by artificial intelligence to treat spontaneous brain bleeding. It aims to improve recovery by precisely removing the clot with less damage to healthy brain tissue.
This trial tests a type of keyhole surgery called neuroendoscopic surgery to remove large blood clots in the brain. It may help people who have had a serious brain bleed and need urgent surgery.
Hear when a new Clarify the Therapeutic Differences Between Robot Assisted Endoscopic Clearance and Traditional Puncture and External Drainag trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.